By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Exalenz Bioscience  

4 Ha` Maayan St

Modiin    71700  Israel
Phone: 972-8-9737500 Fax: 972-8-9737501



Company News
Exalenz Bioscience Launches Pivotal Study Of World’s First Breath-Based Test To Diagnose Clinically Significant Portal Hypertension 10/21/2014 10:58:34 AM
Exalenz Bioscience To Present At Upcoming Investor Conferences 9/29/2014 11:47:14 AM
Deloitte Names Exalenz Bioscience As One Of Israel's Companies-To-Watch In The 2014 Deloitte Technology Fast 50™ Awards 9/23/2014 11:55:39 AM
Exalenz Bioscience Expands Its Breath Testing Technology Into The Potential Billion Dollar Liver Diagnostic Market 5/21/2014 9:00:25 AM
Exalenz Bioscience Granted US Patent for Liver Application of Company’s BreathID Platform Technology 8/21/2013 9:25:22 AM
Exalenz Bioscience Appoints Gavin Doree New VP of Sales to Lead Company's New Direct Sales Organization in the U.S. 7/23/2013 6:40:48 AM
Exalenz Bioscience Announces the Global Market Launch of the New BreathID® Hp for Detection and Management of H. pylori 7/15/2013 10:33:51 AM
Exalenz Bioscience Received FDA Clearance to Market the Next Generation of BreathID® Technology 5/28/2013 8:21:42 AM
Larry Cohen Appointed CEO of Exalenz Bioscience 3/4/2013 7:23:54 AM